Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01418378
Other study ID # CT07/04
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date August 3, 2011
Est. completion date February 17, 2016

Study information

Verified date July 2019
Source DePuy International
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare two very similar designs of knee replacement device. One device (Sigma CR150) is a slightly modified version of the original (Sigma CR) and has been modified to enhance/accommodate higher flexion. The original device has been in widespread clinical use with excellent results since 1996 and this study will determine whether the design modifications of the newer device add further value. The newer device has been in clinical use with good short-term(unpublished) outcomes since becoming commercially available in January 2009.

Achieving higher knee flexion may be required for cultural reasons or by the increasingly younger, more active patient population undergoing knee replacement today. In addition to promoting flexion, it is also possible that this design change may help the knee replacement to last longer than traditional implants in patients who achieve higher flexion. Therefore, the study will compare the two devices in terms of survivorship, flexion and other measures of the success of a total knee replacement (range of motion, knee-related quality of life, activity and generic quality of life) over the short-term.

A minimum of one hundred and forty subjects (minimum 70 per group) with osteoarthritis and aged 50-75 years will be included at UK/international hospitals.

Study duration is 2 years and patients will complete standard knee outcome scores plus radiological evaluation.

Subjects would receive one of the study devices regardless of their involvement in the study, and apart from (possible)additional visits, x-rays and/or questionnaires, treatment and follow-up care will be as per the care they would receive outside of the study.


Recruitment information / eligibility

Status Completed
Enrollment 191
Est. completion date February 17, 2016
Est. primary completion date February 17, 2016
Accepts healthy volunteers No
Gender All
Age group 50 Years to 75 Years
Eligibility Inclusion Criteria:

i)Male or female subjects, aged between 50 and 75 years inclusive.

ii)Subjects who are able to give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained.

iii) Subjects who, in the opinion of the Clinical Investigator, are able to understand this clinical investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.

iv) Subjects defined by the Investigator as ASA Grade I or II.

v) Subjects with a primary diagnosis of osteoarthritis.

vi) Subjects who require a primary total knee arthroplasty.

vii) Subjects who can achieve active flexion of 90 degrees.

Exclusion Criteria:

i) Subjects who, in the opinion of the Clinical Investigator, have an existing condition that would compromise their participation and follow-up in this clinical investigation.

ii) Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.

iii) Subjects who have participated in a clinical investigation with an investigational product in the last month.

iv) Subjects who are currently involved in any injury litigation claims.

v) Subjects with an anatomical limb alignment of above 20 degrees varus or valgus.

vi) Subjects with a fixed flexion deformity of over 20 degrees.

vii) Subjects with recurvatum (definition: hyperextension = 5 degrees).

viii) Subjects who cannot flex their hip to 90 degrees.

ix) Subjects with a BMI of 35 or above.

x) Subjects defined by the Investigator as ASA Grade III-V.

xi) Subjects who are identified pre-operatively as having bone defects which require augmentation.

xii) Subjects who have previously undergone total or unicondylar knee arthroplasty, high tibial osteotomy, ligament reconstruction, ORIF or with previous fracture in the knee joint.

xiii) Subjects with primary or secondary diagnosis of inflammatory or traumatic arthritis.

xiv) Subjects who have undergone contralateral total knee arthroplasty during the previous 6 months.

xv) Subjects who in the opinion of the Investigator require patellar resurfacing.

Intra-operative exclusion criteria:

i) Subjects who have uncontained bone defects or defects bigger than 8 mm3 and/or require augmentation.

ii) Subjects who are not suitable to receive both the study and comparator devices.

iii) Subjects who require patellar resurfacing

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Sigma CR150
Sigma CR150 femoral component used in combination with the Highly Polished Cobalt Chrome fixed bearing tibial tray and the Curved (XLK) polyethylene bearing (cemented, no patellar resurfacing).
Sigma CR
Sigma CR femoral component used in combination with the Highly Polished Cobalt Chrome fixed bearing tibial tray and the Curved (XLK) polyethylene bearing (cemented, no patellar resurfacing).

Locations

Country Name City State
India Sunshine Hospitals Secunderabad Andhra Pradesh
Singapore Singapore General Hospital Singapore
United Kingdom Calderdale Royal Hospital Halifax West Yorkshire
United Kingdom Victoria Hospital Kirkcaldy Fife

Sponsors (1)

Lead Sponsor Collaborator
DePuy International

Countries where clinical trial is conducted

India,  Singapore,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Knees Who Survived at 2 Years Post-operative The Kaplan-Meier success rate at 24-months post-operatively was calculated with Kaplan-Meier time-to-event methodology, where the time variable for patients who were successful (no components revised for any reason) was censored at the time of last follow-up. 2 Years
Secondary Change From Baseline in Goniometer Measured Maximum Passive Flexion at 2 Years Comparative evaluation of the change from baseline values in 2 year goniometer-measured passive flexion. A goniometer is an instrument used to measure angles in degrees and captures the change in angle between the upper and lower leg Pre-operative baseline to 2 years
Secondary Knee Injury and Osteoarthritis Outcome Pain Subscore - 1 Year Comparative evaluation of the change from baseline values at 1 years in Knee Injury and Osteoarthritis Outcome Pain Subscore
The subscore ranges from 0 (no pain) to 36 (extreme pain). The subscore is then transformed into a 0 (extreme pain) to 100 (no pain) scale.
100 - (score x 100) / 36 = transformed score
Pre-operative baseline to 1 year
Secondary Knee Injury and Osteoarthritis Outcome Pain Subscore - 2 Years Comparative evaluation of the change from baseline values at 2 years in Knee Injury and Osteoarthritis Outcome Pain Subscore
The subscore ranges from 0 (no pain) to 36 (extreme pain). The subscore is then transformed into a 0 (extreme pain) to 100 (no pain) scale.
100 - (score x 100) / 36 = transformed score
2 years
Secondary Knee Injury and Osteoarthritis Outcome Symptoms Subscore - 1 Years Comparative evaluation of the change from baseline values at 1 year in Knee Injury and Osteoarthritis Outcome Symptom Subscore
The subscore ranges from 0 (no symptoms) to 36 (always have symptoms). The subscore is then transformed into a 0 (always have symptoms) to 100 (never have symptoms) scale.
100 - (score x 100) / 36 = transformed score
1 years
Secondary Knee Injury and Osteoarthritis Outcome Symptom Subscore - 2 Years Comparative evaluation of the change from baseline values at 2 years in Knee Injury and Osteoarthritis Outcome Symptom Subscore
The subscore ranges from 0 (never have symptoms) to 28 (always have symptoms). The subscore is then transformed into a 0 (always have symptoms) to 100 (never have symptoms) scale.
100 - (score x 100) / 28 = transformed score
2 years
Secondary Knee Injury and Osteoarthritis Outcome - Activities of Daily Living Subscore - 1 Years Comparative evaluation of the change from baseline values at 1 years in Knee Injury and Osteoarthritis Outcome Symptom Subscore
The subscore ranges from 0 (no difficulty) to 68 (extreme difficulty). The subscore is then transformed into a 0 (extreme difficulty) to 100 (no difficulty) scale.
100 - (score x 100) / 68 = transformed score
1 year
Secondary Knee Injury and Osteoarthritis Outcome - Activities of Daily Living Subscore - 2 Years Comparative evaluation of the change from baseline values at 2 years in Knee Injury and Osteoarthritis Outcome Activities of Daily Living Subscore
The subscore ranges from 0 (no difficulty) to 68 (extreme difficulty). The subscore is then transformed into a 0 (extreme difficulty) to 100 (no difficulty) scale.
100 - (score x 100) / 68 = transformed score
2 year
Secondary Knee Injury and Osteoarthritis Outcome - Sport and Recreation Subscore - 1 Years Comparative evaluation of the change from baseline values at 1 years in Knee Injury and Osteoarthritis Outcome Activities of Daily Living Subscore
The subscore ranges from 0 (no difficulty) to 20 (extreme difficulty). The subscore is then transformed into a 0 (extreme difficulty) to 100 (no difficulty) scale.
100 - (score x 100) / 20 = transformed score
1 year
Secondary Knee Injury and Osteoarthritis Outcome Sport and Recreation Subscore - 2 Years Comparative evaluation of the change from baseline values at 2 years in Knee Injury and Osteoarthritis Outcome Activities of Daily Living Subscore
The subscore ranges from 0 (no difficulty) to 20 (extreme difficulty). The subscore is then transformed into a 0 (extreme difficulty) to 100 (no difficulty) scale.
100 - (score x 100) / 20 = transformed score
2 year
Secondary Knee Injury and Osteoarthritis Outcome - Quality of Life Subscore - 1 Years Comparative evaluation of the change from baseline values at 1 years in Knee Injury and Osteoarthritis Outcome Activities of Quality of life Subscore
The subscore ranges from 0 (no difficulty) to 16 (extreme difficulty). The subscore is then transformed into a 0 (extreme difficulty) to 100 (no difficulty) scale.
100 - (score x 100) / 16 = transformed score
1 year
Secondary Knee Injury and Osteoarthritis Outcome - Quality of Life Subscore - 2 Years Comparative evaluation of the change from baseline values at 2 years in Knee Injury and Osteoarthritis Outcome Quality of Life Subscore
The subscore ranges from 0 (no difficulty) to 16 (extreme difficulty). The subscore is then transformed into a 0 (extreme difficulty) to 100 (no difficulty) scale.
100 - (score x 100) / 16 = transformed score
2 years
Secondary Change From Baseline in Goniometer Measured Maximum Passive Flexion at 1 Year. Comparative evaluation of the change from baseline values in 1 year goniometer-measured passive Flexion. A goniometer is an instrument used to measure angles in degrees and captures the change in angle between the upper and lower leg. Passive flexion involves moving the leg through range of motion without active muscle contraction 1 year
Secondary Change From Baseline in Goniometer Measured Maximum Passive Extension at 1 Year Comparative evaluation of the change from baseline values in 1 year goniometer-measured passive extension. A goniometer is an instrument used to measure angles in degrees and captures the change in angle between the upper and lower leg. Passive extension involves the leg being moved without active muscle contraction 1 year
Secondary Change From Baseline in Goniometer Measured Maximum Passive Extension at 2 Years Comparative evaluation of the change from baseline values in 2 year goniometer-measured passive extension. A goniometer is an instrument used to measure angles in degrees and captures the change in angle between the upper and lower leg. Passive extension involves moving the leg without active muscle contraction 2 year
Secondary Change From Baseline in Goniometer Measured Maximum Total Range of Motion at 1 Year Comparative evaluation of the change from baseline values in 1 year goniometer-measured total range of motion. A goniometer is an instrument used to measure angles in degrees and captures the change in angle between the upper and lower leg. Total range of motion is the full distance the lower leg travels in relation to the upper leg. 1 year
Secondary Change From Baseline in Goniometer Measured Maximum Total Range of Motion at 2 Years. Comparative evaluation of the change from baseline values in 2 year goniometer-measured total range of motion. A goniometer is an instrument used to measure angles in degrees and captures the change in angle between the upper and lower leg. Total range of motion is the full distance the lower leg travels in relation to the upper leg. 2 years
Secondary Number of Participants With Flexion Contracture at 1 Year Summary of flexion contracture at 1 year time point. Flexion contracture is a shortening of the muscles that prevents the leg from fully extending 1 years
Secondary Number of Participants With Flexion Contracture at 2 Years Summary of flexion contracture at 2 year time point.Flexion contracture is a shortening of the muscles that prevents the leg from fully extending 2 years
Secondary Total Knee Society Score at 1 Year Total Knee Society Knee Score change from baseline at 1 year
The Total Knee Society Score is comprised of two scores: the Knee Score and the Function Score. Both have a 0-100 range. Sub-scales are combined to compute a total score of 100
The Total Knee Society Score is made up of pain, range of motion, alignment and stability subscores. An Excellent score is 80-100, a good score is 70-79, a fair score is 60-69 and a poor score is anything below 60.
1 year
Secondary Total Knee Society Knee Score at 2 Years Total Knee Society Knee Score change from baseline at 2 years
The Total Knee Society Score is comprised of two scores: the Knee Score and the Function Score. Both have a 0-100 range. Sub-scales are combined to compute a total score of 100
The Total Knee Society Score is made up of pain, range of motion, alignment and stability subscores. An Excellent score is 80-100, a good score is 70-79, a fair score is 60-69 and a poor score is anything below 60.
2 years
Secondary Anatomic Alignment Angle Anatomic angle measured at 1 year time point.
If one draws a line from the center of the hip joint to the center of the ankle joint this is considered to be the mechanical axis of the femur.
A line drawn through the center of the femoral shaft is the anatomic axis.
The angle created at the intersection of these lines is referred to as the anatomic alignment angle.
A normal angle is approximately 7-9 degrees "valgus" or slightly "knock-kneed". "Varus" angles are less common and are also referred to as "bow-legged".
1 year time point
Secondary Anatomic Alignment Angle Anatomic angle measured at 2 year time point.
If one draws a line from the center of the hip joint to the center of the ankle joint this is considered to be the mechanical axis of the femur.
A line drawn through the center of the femoral shaft is the anatomic axis.
The angle created at the intersection of these lines is referred to as the anatomic alignment angle.
A normal angle is approximately 7-9 degrees "valgus" or slightly "knock-kneed". "Varus" angles are less common and are also referred to as "bow-legged".
2 year time point
Secondary Alignment - Femoral Component to Anatomic Angle. Femoral component angle measured at 1 year time point. This angle is measured between a line drawn from the center of the femoral head and a line across the bottom of the femoral implant (condyles). 1 year time point
Secondary Alignment - Femoral Component to Anatomic Angle Femoral component angle measured at 2 year time point. This angle is measured between a line drawn from the center of the femoral head and a line across the bottom of the femoral implant (condyles). 2 year time point
Secondary Alignment - Tibial Component to Anatomic Angle Tibial component angle measured at 1 year time point. This angle is measured between a line drawn from the center of the femoral head tibial implant. 1 year time point
Secondary Alignment - Tibial Component to Anatomic Angle Tibial component angle measured at 2 year time point. This angle is measured between a line drawn from the center of the femoral head tibial implant. 2 year time point
Secondary Alignment - Femoral Component Flexion Femoral Component Flexion measured at 1 year time point. This measures the angle between a line drawn though the center of the side of the femur and a line drawn across the top of the flat inner surface of the femoral component. 1 year time point
Secondary Alignment - Femoral Component Flexion Alignment - Femoral Component Flexion measured at 2 year time point. This measures the angle between a line drawn though the center of the side of the femur and a line drawn across the top of the flat inner surface of the femoral component. 2 year time point
Secondary Alignment - Tibial Posterior Slope Tibial Posterior Slope measured at 1 year time point. This angle is measured between a line through the center of the side of the tibia and the top flat surface of the tibial implant 1 year time point
Secondary Alignment - Tibial Posterior Slope Alignment - Tibial Posterior Slope measured at 2 year time point. This angle is measured between a line through the center of the side of the tibia and the top flat surface of the tibial implant 2 year time point
Secondary Number of Subjects With Radiolucencies - Femoral Component The bone-implant interface at the femoral components were examined radiographically and radiolucencies were measured in millimeters.
Radiolucent lines (RLLs) greater than 2mm are considered to be clinically significant.
6 to 12 week and 24 month intervals
Secondary Number of Subjects With Radiolucencies - Tibial Component The bone-implant interface at the tibial components were examined radiographically and radiolucencies were measured in millimeters.
Radiolucent lines (RLLs) greater than 2mm are considered to be clinically significant.
Radiolucent lines greater than 2mm are considered to be clinically significant.
6 weeks to 24 months
Secondary Radiographic Evaluation of Maximum Flexion Maximum knee flexion measured radiographically at 1 year time point 1 year time point
See also
  Status Clinical Trial Phase
Completed NCT04657926 - A Trial of APPA in the Treatment of Knee Osteoarthritis Phase 2
Completed NCT02536833 - A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Phase 2
Completed NCT03014037 - Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration N/A
Recruiting NCT05937542 - A Qualitative Investigation of CLEAT Participants
Completed NCT03644615 - A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT03850665 - Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach N/A
Completed NCT02826902 - Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial N/A
Completed NCT04402502 - Dynamic 4DCT to Examine Wrist Carpal Mechanics N/A
Completed NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial Phase 4
Completed NCT04564053 - Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants Phase 1
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT05036174 - Diphenhydramine Ointment for Knee Osteoarthritis N/A
Recruiting NCT02912429 - Onlay vs. Inlay Patellofemoral Arthroplasty N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Active, not recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee
Withdrawn NCT02921594 - Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties N/A
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A